Skip to main content

Dibenzepin

ADVERTISEMENT
Identification
Molecular formula
C19H21N3
CAS number
25969-81-7
IUPAC name
3-(5,6-dihydrobenzo[b][1,4]benzodiazepin-11-yl)-N,N-dimethyl-propan-1-amine
State
State

At room temperature, Dibenzepin is typically a solid. It is stable under normal conditions but should be stored in a dry, cool place to preserve its integrity.

Melting point (Celsius)
137.00
Melting point (Kelvin)
410.15
Boiling point (Celsius)
161.00
Boiling point (Kelvin)
434.15
General information
Molecular weight
293.41g/mol
Molar mass
293.4050g/mol
Density
1.2000g/cm3
Appearence

Dibenzepin appears as a crystalline solid, typically in the form of powder. The color can range from white to off-white. It is often odorless.

Comment on solubility

Solubility of 3-(5,6-Dihydrobenzo[b][1,4]benzodiazepin-11-yl)-N,N-dimethyl-propan-1-amine

The solubility of 3-(5,6-dihydrobenzo[b][1,4]benzodiazepin-11-yl)-N,N-dimethyl-propan-1-amine can be influenced by several factors, including its structural characteristics and the solvent used.

Key Factors Affecting Solubility:

  • Polarity: The presence of polar functional groups may enhance solubility in polar solvents like water.
  • Hydrogen Bonding: Capable hydrogen bonding interactions can lead to increased solubility in organic solvents.
  • Molecular Weight: Generally, higher molecular weights can complicate solubility.

As a result of these factors, this compound may exhibit variable solubility:

  • Possibly soluble in organic solvents such as DMSO and ethanol.
  • Potentially insoluble in water, due to the complex structure and the presence of the benzodiazepine moiety.

In summary, understanding solubility is crucial for the application of this compound in various environments. Thus, it is advisable to:

  • Conduct solubility experiments in different solvents.
  • Consider the potential need for solubilizing agents or complexation strategies.

Overall, the specific solubility profile of this compound is best determined through experimental analysis, but the structural properties provide a crucial insight into its behavior in various mediums.

Interesting facts

Interesting Facts about 3-(5,6-dihydrobenzo[b][1,4]benzodiazepin-11-yl)-N,N-dimethyl-propan-1-amine

This intriguing compound belongs to the benzodiazepine family, which is renowned for its effects on the central nervous system. Benzodiazepines are primarily used in medicine for their anxiolytic (anxiety-reducing), sedative, and anticonvulsant properties. Here are some fascinating insights into this specific compound:

  • Structural Complexity: The compound features a unique structure that integrates a benzodiazepine core with an additional dimethylamino propan-1-amine group, enhancing its pharmacological potential.
  • Potential Applications: Due to its structural characteristics, this compound may contribute to research surrounding new anxiolytic or antidepressant medications, aiming to minimize side effects associated with traditional benzodiazepines.
  • Research Interest: Scientists are encouraged to explore the interactions this compound may have with specific receptors in the brain, such as GABAA receptors, which are fundamental in regulating neural excitability.
  • Chemical Synthesis: The synthesis of this compound may involve intricate steps of organic reactions, presenting a valuable learning opportunity for chemistry students interested in medicinal chemistry.
  • Pharmacodynamics: Understanding how this compound interacts at a molecular level can provide insights into developing tailored therapies for anxiety disorders while addressing challenges like dependency.

In conclusion, 3-(5,6-dihydrobenzo[b][1,4]benzodiazepin-11-yl)-N,N-dimethyl-propan-1-amine represents an exciting frontier in medicinal chemistry. Its complex structure and potential for therapeutic application make it a noteworthy compound for further investigation.

Synonyms
BRN 0891351
2204-53-7
5H-DIBENZO(b,e)(1,4)DIAZEPINE, 10,11-DIHYDRO-5-(3-(DIMETHYLAMINO)PROPYL)-
DTXSID40176511
5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenzo(b,e)(1,4)diazepine
DTXCID7099002
5-23-08-00274 (beilstein handbook reference)